About HMS (NASDAQ:HMSY)
HMS Holdings Corp. is a holding company. The Company, through its subsidiaries, operates in the United States healthcare insurance benefit cost containment marketplace. It provides coordination of benefits services to government, and private healthcare payers and sponsors. Its payment integrity services ensure that healthcare claims billed are accurate and appropriate. It offers services to state Medicaid agencies, government health agencies and health plans, including Medicaid managed care, Medicare Advantage and group and individual health lines of business; government and private employers; and other healthcare payers and sponsors, including child support agencies. It serves approximately 45 state Medicaid programs and the District of Columbia, and government health agencies, including Centers for Medicare & Medicaid Services (CMS) and the Veterans Health Administration (VHA). It also provides services to approximately 250 health plans and supports their multiple lines of business.
Industry, Sector and Symbol
Industry MEDICAL CARE
Sub-IndustryHealth Care Technology
Trailing P/E Ratio36.3703558773017
Forward P/E Ratio25.74
Sales & Book Value
Annual Sales$521.21 million
Price / Sales2.66
Cash Flow$1.05 per share
Price / Cash15.96
Book Value$7.21 per share
Price / Book2.32
Net Income$40.05 million
Return on Equity7.33%
Return on Assets4.54%
HMS (NASDAQ:HMSY) Frequently Asked Questions
What is HMS's stock symbol?
HMS trades on the NASDAQ under the ticker symbol "HMSY."
How will HMS's stock buyback program work?
HMS announced that its board has approved a stock buyback program on Saturday, November 4th 2017, which permits the company to repurchase $50,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Stock repurchase programs are often a sign that the company's board believes its shares are undervalued.
How were HMS's earnings last quarter?
HMS Holdings Corp (NASDAQ:HMSY) issued its quarterly earnings results on Friday, February, 23rd. The business services provider reported $0.15 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.22 by $0.07. The business services provider had revenue of $148.49 million for the quarter, compared to analyst estimates of $136.77 million. HMS had a net margin of 7.56% and a return on equity of 7.33%. HMS's quarterly revenue was up 18.2% on a year-over-year basis. During the same quarter last year, the firm earned $0.20 EPS. View HMS's Earnings History.
When will HMS make its next earnings announcement?
Where is HMS's stock going? Where will HMS's stock price be in 2018?
8 brokerages have issued twelve-month target prices for HMS's stock. Their predictions range from $17.00 to $26.00. On average, they expect HMS's stock price to reach $20.31 in the next year. View Analyst Ratings for HMS.
What are Wall Street analysts saying about HMS stock?
Here are some recent quotes from research analysts about HMS stock:
- 1. According to Zacks Investment Research, "HMS Holdings Corp. is a leading provider of cost containment solutions in the U.S. healthcare marketplace. Using innovative technology as well as extensive data services and powerful analytics, the Company delivers coordination of benefits, payment integrity, and health management and member engagement solutions to help customers recover improper payments; prevent future improper payments; reduce fraud, waste and abuse; effectively engage their members and better manage the care they receive; and ensure regulatory compliance. The Company serves commercial health plans, state government agencies, federal programs, at-risk providers, pharmacy benefit managers and employers. " (2/28/2018)
- 2. Cantor Fitzgerald analysts commented, "Solid 4Q17 results. On February 23, HMSY reported solid 4Q17 results. Revenue of $148.5 million came in ahead of FactSet consensus of $136.8 million and our estimate of $139.6 million. Revenue growth was broad-based, with double digit growth in both COB and PI. Following a timing related decline in 3Q17, COB revenue of $105.7 million grew 17.4% q/q. About $6-$8 million of COB revenue is attributable to 3Q17. PI revenue of $26.8 million grew 12.2% q/ q and benefited from the implementation of enhanced analytics. PI performance seems to be improving. Eliza revenue of $12.9 million grew 30% q/q as Eliza’s revenue tends to be back-end loaded, with 3Q and 4Q being the strongest. As year end approaches, clients seek to maximize Medicare Star ratings and HEDIS measures. Management expects Eliza to contribute meaningfully to revenue growth in 2018. Adjusted EPS of $0.49 included a $0.25 non-cash tax benefit." (2/23/2018)
Who are some of HMS's key competitors?
Some companies that are related to HMS include Teladoc (TDOC), Magellan Health (MGLN), Select Medical (SEM), Tenet Healthcare (THC), Allscripts Healthcare Solutions (MDRX), Amedisys (AMED), Intrexon (XON), Novocure (NVCR), LifePoint Health (LPNT), Omnicell (OMCL), Tivity Health (TVTY), Irhythm Technologies (IRTC), The Ensign Group (ENSG), China Cord Blood (CO), Medpace (MEDP), iKang Healthcare Group (KANG), Brookdale Senior Living (BKD) and LHC Group (LHCG).
Who are HMS's key executives?
HMS's management team includes the folowing people:
- William C. Lucia, Chairman of the Board, President, Chief Executive Officer (Age 59)
- Jeffrey Scott Sherman, Chief Financial Officer, Executive Vice President, Treasurer (Age 51)
- Douglas M. Williams, President - Markets and Product (Age 58)
- Tracy A. South, Executive Vice President of Human Resources, Chief Administrative Officer (Age 59)
- Meredith W. Bjorck, Executive Vice President, General Counsel, Corporate Secretary (Age 41)
- Semone Wagner Neuman, Executive Vice President - Operations and Information Technology (Age 53)
- Cynthia Nustad, Executive Vice President, Chief Strategy Officer (Age 46)
- Richard H. Stowe, Lead Independent Director (Age 73)
- Robert Becker, Independent Director (Age 63)
- Craig R. Callen, Independent Director (Age 61)
Has HMS been receiving favorable news coverage?
News articles about HMSY stock have been trending somewhat positive recently, according to Accern Sentiment. The research group scores the sentiment of media coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. HMS earned a media sentiment score of 0.08 on Accern's scale. They also assigned media headlines about the business services provider an impact score of 45.45 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the near term.
Who are HMS's major shareholders?
HMS's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (12.86%), Bank of New York Mellon Corp (3.59%), Stephens Investment Management Group LLC (3.28%), American Capital Management Inc. (2.90%), Goldman Sachs Group Inc. (2.21%) and Pembroke Management LTD (2.01%). Company insiders that own HMS stock include Bart M Schwartz, Cynthia Nustad, Douglas M Williams, Richard H Stowe, Robert Becker, Robert M Holster, Semone Neuman and William C Lucia. View Institutional Ownership Trends for HMS.
Which institutional investors are selling HMS stock?
HMSY stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., GW&K Investment Management LLC, Renaissance Technologies LLC, Tygh Capital Management Inc., American Capital Management Inc., Pembroke Management LTD, Stephens Investment Management Group LLC and TIAA CREF Investment Management LLC. Company insiders that have sold HMS company stock in the last year include Cynthia Nustad, Douglas M Williams, Semone Neuman and William C Lucia. View Insider Buying and Selling for HMS.
Which institutional investors are buying HMS stock?
HMSY stock was purchased by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Millennium Management LLC, BlackRock Inc., HCSF Management LLC, DnB Asset Management AS, Eagle Boston Investment Management Inc., PEAK6 Investments L.P. and Two Sigma Advisers LP. Company insiders that have bought HMS stock in the last two years include Bart M Schwartz and Robert Becker. View Insider Buying and Selling for HMS.
How do I buy shares of HMS?
Shares of HMSY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is HMS's stock price today?
One share of HMSY stock can currently be purchased for approximately $16.73.
How big of a company is HMS?
HMS has a market capitalization of $1.40 billion and generates $521.21 million in revenue each year. The business services provider earns $40.05 million in net income (profit) each year or $0.46 on an earnings per share basis. HMS employs 2,500 workers across the globe.
How can I contact HMS?
HMS's mailing address is 5615 High Point Drive, Irving TX, 75038. The business services provider can be reached via phone at 214-453-3000 or via email at [email protected]
MarketBeat Community Rating for HMS (HMSY)MarketBeat's community ratings are surveys of what our community members think about HMS and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
HMS (NASDAQ:HMSY) Analysts' Consensus Rating (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Today||30 Days Ago||90 Days Ago||180 Days Ago|
|Consensus Rating: ||Buy||Buy||Buy||Buy|
|Consensus Rating Score: ||2.75||2.67||2.75||2.88|
|Ratings Breakdown: ||0 Sell Rating(s)|
3 Hold Rating(s)
4 Buy Rating(s)
1 Strong Buy Rating(s)
|0 Sell Rating(s)|
4 Hold Rating(s)
4 Buy Rating(s)
1 Strong Buy Rating(s)
|0 Sell Rating(s)|
3 Hold Rating(s)
4 Buy Rating(s)
1 Strong Buy Rating(s)
|0 Sell Rating(s)|
2 Hold Rating(s)
5 Buy Rating(s)
1 Strong Buy Rating(s)
|Consensus Price Target: ||$20.31||$20.19||$20.19||$23.06|
|Price Target Upside: ||21.41% upside||18.19% upside||23.40% upside||30.15% upside|
HMS (NASDAQ:HMSY) Consensus Price Target History
HMS (NASDAQ:HMSY) Analyst Ratings History
(Data available from 3/22/2016 forward)
HMS (NASDAQ:HMSY) Earnings History and Estimates Chart
HMS (NASDAQ HMSY) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|2/23/2018||Q4 2017||$0.22||$0.15||$136.77 million||$148.49 million||View||Listen|
|11/3/2017||Q3 2017||$0.22||$0.19||$147.62 million||$125.70 million||View||N/A|
|8/4/2017||Q2 2017||$0.18||$0.16||$135.96 million||$133.31 million||View||N/A|
|5/10/2017||Q1 17||$0.15||$0.14||$120.08 million||$114.50 million||View||N/A|
|2/24/2017||Q416||$0.19||$0.20||$130.85 million||$128.10 million||View||N/A|
|11/9/2016||Q316||$0.17||$0.24||$123.43 million||$124.60 million||View||Listen|
|8/5/2016||Q216||$0.15||$0.18||$116.85 million||$123.60 million||View||N/A|
|5/6/2016||Q1||$0.12||$0.14||$115.00 million||$119.80 million||View||N/A|
|2/26/2016||Q415||$0.16||$0.19||$122.12 million||$128.50 million||View||Listen|
|11/6/2015||Q315||$0.15||$0.15||$119.85 million||$118.40 million||View||N/A|
|8/7/2015||Q215||$0.13||$0.10||$114.86 million||$113.00 million||View||N/A|
|5/8/2015||Q115||$0.11||$0.11||$108.60 million||$108.00 million||View||N/A|
|2/27/2015||Q414||$0.16||$0.03||$116.40 million||$112.20 million||View||N/A|
|11/4/2014||Q314||$0.13||$0.14||$109.47 million||$112.40 million||View||N/A|
|8/8/2014||Q214||$0.11||$0.12||$106.44 million||$112.56 million||View||N/A|
|5/9/2014||Q214||$0.15||$0.09||$114.66 million||$104.70 million||View||N/A|
|2/28/2014||Q413||$0.24||$0.20||$131.94 million||$121.60 million||View||N/A|
|11/8/2013||Q313||$0.23||$0.20||$127.13 million||$127.80 million||View||N/A|
|7/26/2013||Q2 2013||$0.21||$0.20||$123.69 million||$125.80 million||View||N/A|
|4/26/2013||Q1 2013||$0.18||$0.15||$123.83 million||$116.60 million||View||N/A|
|2/22/2013||Q4 2012||$0.25||$0.27||$134.57 million||$133.10 million||View||N/A|
|10/26/2012||Q312||$0.15||$0.20||$118.70 million||$113.20 million||View||N/A|
HMS (NASDAQ:HMSY) Earnings Estimates
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for HMS (NASDAQ:HMSY)
No dividend announcements for this company have been tracked by MarketBeat.com
HMS (NASDAQ HMSY) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 3.20%
Institutional Ownership Percentage: 99.42%
HMS (NASDAQ HMSY) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|9/27/2017||William C Lucia||Chairman||Sell||29,894||$20.00||$597,880.00||222,745|| |
|8/31/2017||Cynthia Nustad||EVP||Sell||22,907||$17.64||$404,079.48||73,877|| |
|8/28/2017||Semone Neuman||EVP||Sell||20,734||$17.68||$366,577.12||96,722|| |
|8/9/2017||Douglas M Williams||Insider||Sell||13,140||$17.78||$233,629.20||121,264|| |
|6/12/2017||Bart M Schwartz||Director||Buy||1,500||$19.28||$28,920.00||46,868|| |
|6/9/2017||Semone Neuman||EVP||Sell||14,546||$19.00||$276,374.00||122,685|| |
|9/26/2016||William C Lucia||CEO||Sell||45,280||$22.09||$1,000,235.20||194,982|| |
|9/14/2016||Robert Becker||Director||Buy||5,000||$21.96||$109,800.00||11,701|| |
|6/21/2016||William C Lucia||CEO||Sell||152,025||$17.75||$2,698,443.75||205,918|| |
|6/20/2016||William C Lucia||CEO||Sell||60,356||$18.00||$1,086,408.00||205,918|| |
|6/8/2016||Richard H Stowe||Director||Sell||20,000||$18.11||$362,200.00||67,818|| |
|6/7/2016||Cynthia Nustad||EVP||Sell||10,995||$17.79||$195,601.05||93,316|| |
|6/1/2016||Robert M Holster||Director||Sell||20,000||$17.58||$351,600.00||102,188|| |
|6/1/2016||Semone Neuman||EVP||Sell||5,124||$17.60||$90,182.40||106,200|| |
|3/8/2016||Semone Neuman||EVP||Sell||7,992||$14.25||$113,886.00||113,254|| |
|3/1/2016||Robert M Holster||Director||Sell||100,000||$13.52||$1,352,000.00||122,188|| |
|12/9/2015||Robert M Holster||Director||Sell||20,000||$12.68||$253,600.00||181,188|| |
|11/23/2015||Richard H Stowe||Director||Sell||30,000||$11.47||$344,100.00||84,253|| |
|11/18/2015||Semone Neuman||EVP||Sell||1,454||$11.79||$17,142.66||89,534|| |
|11/11/2015||Robert M. Holster||Director||Sell||16,999||$11.19||$190,218.81||190,188|| |
|8/13/2015||Jeffrey Scott Sherman||CFO||Buy||10,760||$9.30||$100,068.00|| |
|8/12/2015||Eugene V Defelice||EVP||Buy||2,000||$8.79||$17,580.00|| |
|7/10/2015||Robert M Holster||Director||Sell||7,000||$16.00||$112,000.00|| |
|6/12/2015||Robert M Holster||Director||Sell||7,000||$17.56||$122,920.00|| |
|5/18/2015||Semone Wagner||EVP||Sell||6,477||$16.68||$108,036.36|| |
|4/21/2015||Robert M Holster||Director||Sell||3,000||$16.00||$48,000.00|| |
|1/9/2015||Robert M Holster||Director||Sell||7,000||$21.06||$147,420.00|| |
|12/15/2014||William C Lucia||CEO||Sell||13,902||$20.20||$280,820.40|| |
|12/12/2014||Robert M Holster||Director||Sell||7,000||$20.93||$146,510.00|| |
|12/8/2014||Ellen A Rudnick||Director||Sell||10,000||$22.46||$224,600.00|| |
|11/28/2014||Ellen A Rudnick||Director||Sell||35,000||$21.10||$738,500.00|| |
|11/17/2014||William C Lucia||CEO||Sell||13,858||$21.24||$294,343.92|| |
|9/15/2014||William C Lucia||CEO||Sell||13,693||$20.71||$283,582.03|| |
|8/21/2014||William F Miller III||Director||Sell||25,000||$23.03||$575,750.00|| |
|5/19/2014||Bart Schwartz||Director||Buy||1,500||$17.29||$25,935.00||20,623|| |
|5/19/2014||Eugene Defelice||EVP||Buy||1,000||$17.29||$17,290.00||10,980|| |
|5/15/2014||Craig Callen||Director||Buy||3,000||$17.39||$52,170.00||10,530|| |
|1/17/2014||Robert Holster||Director||Sell||5,000||$25.83||$129,150.00||216,543|| |
|1/15/2014||William Lucia||CEO||Sell||20,000||$25.02||$500,400.00||305,426|| |
|1/14/2014||Robert Holster||Director||Sell||10,000||$24.00||$240,000.00||218,543|| |
|12/5/2013||Christina Dragonetti||Insider||Sell||12,000||$22.32||$267,840.00||195,526|| |
|11/8/2013||Christina Dragonetti||Insider||Sell||12,000||$22.00||$264,000.00||207,526|| |
|10/4/2013||Christina Dragonetti||Insider||Sell||12,000||$22.00||$264,000.00||219,526|| |
|9/5/2013||Christina Dragonetti||Insider||Sell||12,000||$24.21||$290,520.00|| |
|8/1/2013||Christina Dragonetti||Insider||Sell||12,000||$24.30||$291,600.00|| |
|7/5/2013||Christina Dragonetti||Insider||Sell||12,000||$23.26||$279,120.00|| |
|6/12/2013||William F Miller III||Director||Sell||3,000||$22.53||$67,590.00|| |
|6/6/2013||Christina Dragonetti||Insider||Sell||12,000||$24.03||$288,360.00|| |
|3/4/2013||Andrea Benko||EVP||Sell||1,449||$29.48||$42,716.52|| |
HMS (NASDAQ HMSY) News Headlines
HMS (NASDAQ:HMSY) SEC Filings
This page is loading this company's SEC Filings. Please wait...
HMS (NASDAQ:HMSY) Income Statement, Balance Sheet and Cash Flow Statement
HMS (NASDAQ HMSY) Stock Chart for Thursday, March, 22, 2018